APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 78 filers reported holding APPLIED MOLECULAR TRANS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,364,185 | -39.2% | 8,689,075 | -0.1% | 0.71% | -37.5% |
Q2 2023 | $2,243,120 | -37.6% | 8,694,264 | -0.3% | 1.13% | -37.5% |
Q1 2023 | $3,595,287 | -2.4% | 8,721,447 | -0.5% | 1.81% | -9.9% |
Q4 2022 | $3,683,056 | -58.3% | 8,769,181 | -3.3% | 2.01% | -53.8% |
Q3 2022 | $8,825,000 | -66.5% | 9,069,582 | +0.1% | 4.35% | -58.0% |
Q2 2022 | $26,376,000 | -61.5% | 9,063,746 | -0.4% | 10.35% | -44.6% |
Q1 2022 | $68,423,000 | -46.1% | 9,098,780 | +0.3% | 18.70% | -17.0% |
Q4 2021 | $126,875,000 | -45.6% | 9,075,488 | +0.7% | 22.54% | -6.4% |
Q3 2021 | $233,064,000 | -41.9% | 9,009,055 | +2.8% | 24.09% | -42.5% |
Q2 2021 | $400,899,000 | +4.7% | 8,764,720 | +0.8% | 41.88% | -2.0% |
Q1 2021 | $382,793,000 | +43.6% | 8,697,874 | +0.4% | 42.74% | +1.3% |
Q4 2020 | $266,577,000 | -3.3% | 8,663,547 | +0.0% | 42.20% | +7.0% |
Q3 2020 | $275,672,000 | +26.8% | 8,663,466 | +0.2% | 39.44% | +7.7% |
Q2 2020 | $217,401,000 | – | 8,647,640 | – | 36.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 3,611,615 | $567,024 | 70.62% |
Founders Fund VI Management, LLC | 826,607 | $129,777 | 0.98% |
EPIQ Capital Group, LLC | 8,689,075 | $1,364,185 | 0.71% |
GEODE CAPITAL MANAGEMENT, LLC | 139,808 | $21,949 | 0.00% |
OSAIC HOLDINGS, INC. | 500 | $78 | 0.00% |
STATE STREET CORP | 55,055 | $8,644 | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 650 | $0 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 49,958 | $7,843 | 0.00% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 66,207 | $10,395 | 0.00% |
Qube Research & Technologies Ltd | 2,104 | $330 | 0.00% |